Sterling Pharma Solutions
Trending Articles
Related Content
Regulatory
A risk mitigation approach to detecting and quantifying metals in APIs
If trace quantities of metals are present in active pharmaceutical ingredients (APIs) or final drug products, they have the potential to adversely affect patients, depending on the dose, particularly if the metal is toxic, writes Scott Hugill, Analytical Department Manager for Sterling Pharma Solutions